Tricuspid stenosis echocardiography: Difference between revisions

Jump to navigation Jump to search
 
(12 intermediate revisions by one other user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Tricuspid stenosis}}
{{Tricuspid stenosis}}
{{CMG}}
{{CMG}}; {{AE}} {{Rim}}


==Overview==
==Overview==
[[Transthoracic echocardiography]] ([[TTE]]) should be performed in a patient with suspected tricuspid stenois to confirm the diagnosis, determine the etiology, and establish the baseline severity. [[Echocardiography]] is useful for the assessment of the function of the [[right ventricle]] prior to surgery.
[[Transthoracic echocardiography]] ([[TTE]]) should be performed among patients with suspected tricuspid stenosis (TS) to confirm the diagnosis, determine the etiology, and establish the baseline severity. TTE commonly reveals other findings such as [[tricuspid regurgitation]] and/or [[mitral stenosis]]. TS is mainly characterized by an elevated transvalvular gradient.<ref name="pmid19065003">{{cite journal| author=Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP et al.| title=Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. | journal=Eur J Echocardiogr | year= 2009 | volume= 10 | issue= 1 | pages= 1-25 | pmid=19065003 | doi=10.1093/ejechocard/jen303 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19065003  }} </ref>


==Echocardiography==
==Echocardiography==
=== 2D-Echocardiography ===
TTE is performed among patients with suspected TS to confirm the diagnosis and to determine the anatomic and hemodynamic characteristics of the [[tricuspid valve]]. TTE allows the evaluation of the following:<ref name="pmid19065003">{{cite journal| author=Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP et al.| title=Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. | journal=Eur J Echocardiogr | year= 2009 | volume= 10 | issue= 1 | pages= 1-25 | pmid=19065003 | doi=10.1093/ejechocard/jen303 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19065003  }} </ref>
2D-echocardiography is useful to identify the following:
* [[Tricuspid valve]] thickening and calcification
* Thickening of valve leaflets
* Chordal thickening and calcification
* Calcification
* Decreased mobility
* restricted mobility
* Immobility of the leaflets (suggestive of [[carcinoid syndrome]])
* " Doming " of the leaflets
* [[Tumor]]s or [[metastatic lesions]]
* Valvular  vegetations (suggestive of [[infective endocarditis]])
* Right atrial ball valve [[thrombus]]
 
[[Doppler echocardiography]] is useful to assess the severity of TS through the evaluation of the transvalvular gradient. TS is mainly characterized by an elevated transvalvular gradient.<ref name="pmid19065003">{{cite journal| author=Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP et al.| title=Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. | journal=Eur J Echocardiogr | year= 2009 | volume= 10 | issue= 1 | pages= 1-25 | pmid=19065003 | doi=10.1093/ejechocard/jen303 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19065003  }} </ref> Using continuous wave doppler across the [[tricuspid valve]], the peak gradient can be calculated using the modified [[Bernoulli equation]]. Pressure half time can be used but is not validated for TS. The assessment of the [[tricuspid valve]] area is limited by the common association of TS with [[tricuspid regurgitation]]. The coexistence of tricuspid regurgitation causes the underestimation of the tricuspid valvular area.  A tricuspid valve area  < 1.0 cm<sup>2</sup> is associated with increased severity of the TS. The tricuspid valve area can be calculated using the [[continuity equation]]:<ref name="pmid2591399">{{cite journal| author=Fawzy ME, Mercer EN, Dunn B, al-Amri M, Andaya W| title=Doppler echocardiography in the evaluation of tricuspid stenosis. | journal=Eur Heart J | year= 1989 | volume= 10 | issue= 11 | pages= 985-90 | pmid=2591399 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2591399  }} </ref>


=== Doppler Echocardiography ===
Doppler echocardiography is useful to assess the severity of tricuspid stenosis through the evaluation of the transvalvular gradient.
* Using continuous wave doppler across the tricuspid valve in apical-4-chamber view, the peak gradient can be calculated using the modified [[Bernoulli equation]].
* Pressure half time can be used but is not validated for triscuspid stenosis.
* Calculation of tricuspid valve area with the [[continuity equation]] <br>
Tricuspid valve area = ( annulus PW Vti * Cross sectional area of the annulus) / valve CW Vti
Tricuspid valve area = ( annulus PW Vti * Cross sectional area of the annulus) / valve CW Vti


=== Assessment of Tricuspid Stenosis Severity with Echocardiography ===
=== Findings Associated with Increased Severity===
TTE findings that are associated with increased severity of tricuspid stenosis include:
TTE findings that are associated with increased severity of tricuspid stenosis include:<ref name="pmid19065003">{{cite journal| author=Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP et al.| title=Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. | journal=Eur J Echocardiogr | year= 2009 | volume= 10 | issue= 1 | pages= 1-25 | pmid=19065003 | doi=10.1093/ejechocard/jen303 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19065003  }} </ref>
* Valve thickening and calcification
* Chordal thickening and calcification
* Mean pressure gradient >5 mm Hg,
* Mean pressure gradient >5 mm Hg,
* Pressure half-time >190 milliseconds
* Pressure half-time >190 milliseconds
* Tricuspid valve area  < 1.0 cm2
* Tricuspid valve area  < 1.0 cm2
* Enlargement of the right atrium
* Enlargement of the [[right atrium]]
* Enlargement of the inferior vena cava
* Enlargement of the [[inferior vena cava]]
 
{| border = 1
 
|+ '''Severity of tricuspid stenosis'''
 
! |Severity|| mild||moderate || severe
|-
| Tricuspid valve area  || - || - || <1
|-
| Mean Pressure Gradient || <4 || 4-7 || >7
 
|}
 
=== Differential Diagnosis of a Tricuspid Mass Causing Obstruction===
 
* Right atrial tumor
* Right atrial ball valve thrombus
* Large vegetations


==2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary<ref name="pmid24589852">{{cite journal| author=Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA et al.| title=2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. | journal=Circulation | year= 2014 | volume=  | issue=  | pages=  | pmid=24589852 | doi=10.1161/CIR.0000000000000029 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24589852  }} </ref>==
==2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary<ref name="pmid24589852">{{cite journal| author=Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA et al.| title=2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. | journal=Circulation | year= 2014 | volume=  | issue=  | pages=  | pmid=24589852 | doi=10.1161/CIR.0000000000000029 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24589852  }} </ref>==
Line 54: Line 33:
| colspan="1" style="text-align:center; background:LightGreen"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class I]]
| colspan="1" style="text-align:center; background:LightGreen"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class I]]
|-
|-
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''1.''' [[TTE]] is indicated in patients with [[TS]] to assess the anatomy of the valve complex, evaluate severity of stenosis, and characterize any associated regurgitation and/or left-sided valve disease.  ([[ACC AHA guidelines classification scheme#Level of Evidence|''Level of Evidence: C'']])<nowiki>"</nowiki>
| bgcolor="lightgreen" |<nowiki>"</nowiki>'''1.''' [[TTE]] is indicated in patients with [[TS]] to assess the anatomy of the valve complex, evaluate severity of stenosis, and characterize any associated regurgitation and/or left-sided valve disease.  ([[ACC AHA guidelines classification scheme#Level of Evidence|''Level of Evidence: C'']])<nowiki>"</nowiki>
|-
|-
|}
|}

Latest revision as of 19:22, 12 December 2016

Tricuspid stenosis Microchapters

Home

Patient Information

Overview

Classification

Pathophysiology

Causes

Differentiating Tricuspid stenosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Tricuspid stenosis echocardiography On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Tricuspid stenosis echocardiography

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Tricuspid stenosis echocardiography

CDC on Tricuspid stenosis echocardiography

Tricuspid stenosis echocardiography in the news

Blogs on Tricuspid stenosis echocardiography

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Tricuspid stenosis echocardiography

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2]

Overview

Transthoracic echocardiography (TTE) should be performed among patients with suspected tricuspid stenosis (TS) to confirm the diagnosis, determine the etiology, and establish the baseline severity. TTE commonly reveals other findings such as tricuspid regurgitation and/or mitral stenosis. TS is mainly characterized by an elevated transvalvular gradient.[1]

Echocardiography

TTE is performed among patients with suspected TS to confirm the diagnosis and to determine the anatomic and hemodynamic characteristics of the tricuspid valve. TTE allows the evaluation of the following:[1]

Doppler echocardiography is useful to assess the severity of TS through the evaluation of the transvalvular gradient. TS is mainly characterized by an elevated transvalvular gradient.[1] Using continuous wave doppler across the tricuspid valve, the peak gradient can be calculated using the modified Bernoulli equation. Pressure half time can be used but is not validated for TS. The assessment of the tricuspid valve area is limited by the common association of TS with tricuspid regurgitation. The coexistence of tricuspid regurgitation causes the underestimation of the tricuspid valvular area. A tricuspid valve area < 1.0 cm2 is associated with increased severity of the TS. The tricuspid valve area can be calculated using the continuity equation:[2]

Tricuspid valve area = ( annulus PW Vti * Cross sectional area of the annulus) / valve CW Vti

Findings Associated with Increased Severity

TTE findings that are associated with increased severity of tricuspid stenosis include:[1]

  • Mean pressure gradient >5 mm Hg,
  • Pressure half-time >190 milliseconds
  • Tricuspid valve area < 1.0 cm2
  • Enlargement of the right atrium
  • Enlargement of the inferior vena cava

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary[3]

Class I
"1. TTE is indicated in patients with TS to assess the anatomy of the valve complex, evaluate severity of stenosis, and characterize any associated regurgitation and/or left-sided valve disease. (Level of Evidence: C)"

References

  1. 1.0 1.1 1.2 1.3 Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP; et al. (2009). "Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice". Eur J Echocardiogr. 10 (1): 1–25. doi:10.1093/ejechocard/jen303. PMID 19065003.
  2. Fawzy ME, Mercer EN, Dunn B, al-Amri M, Andaya W (1989). "Doppler echocardiography in the evaluation of tricuspid stenosis". Eur Heart J. 10 (11): 985–90. PMID 2591399.
  3. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA; et al. (2014). "2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines". Circulation. doi:10.1161/CIR.0000000000000029. PMID 24589852.

Template:WH

Template:WS